baber/WOPTO huggingface dataset:
Patent NZ-541896-A (NZ)
Title: Computerized password verification system and method for ATM transactions
Inventor: RUSSIKOFF RONALD K
IPC: G07F19/00
Filed: 2004-02-05
Abstract: An automatic teller machine system of the type used to dispense cash to a customer and having a display screen has means for inputting customer selections, means for reading a transaction card with a personal identification number of the customer stored therein and a central computer for processing a cash request from the customer. The automatic teller machine further has a first means for instructing the central computer to generate a plurality of transaction acceptance passwords after the personal identification number is read into the central computer and verified. One of the plurality of passwords is pre-assigned to the customer and stored in the central computer. The automatic teller machine further has a second means for instructing the central computer to display the plurality of passwords on the display screen grouped in a list and having a prompt to the customer for selection of the pre-assigned password; third means for instructing the central computer to dispense the cash request upon the inputted selection of the pre-assigned password; and fourth means for instructing the central computer to signal authorities of a duress cash request upon the inputted selection of one of the plurality of passwords other than the pre-assigned password and further to dispense a limited amount of cash in response to the request.
Patent NZ-547555-A (NZ)
Title: New process for the synthesis of (2S,3aS,7aS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid compounds and application in the synthesis of perindopril
Inventor: DUBUFFET THIERRY
IPC: C07K5/06
Filed: 2004-12-09
Abstract: The disclosure relates to a method for the synthesis of compounds having formula (I), wherein R represents a hydrogen atom or an amino function protecting group. The disclosure also relates to the use of the compounds formula (I) for synthesizing perindopril and the pharmaceutically-acceptable salts thereof.
Patent NZ-549628-A (NZ)
Title: Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
Inventor: FUSHIMI NOBUHIKO
IPC: A61K31/7056
Filed: 2005-03-03
Abstract: Disclosed are nitrogenous fused-ring derivatives represented by the general formula (I) which exert human SGLT inhibiting activity and are useful as preventive or therapeutic agents for diseases caused by hyperglycemia, for example, diabetes, postprandial hyperglycemia, impaired glucose tolerance, complications of diabetes, and obesity; pharmacologically acceptable salts of the derivatives; medicinal compositions containing them; and use thereof as drugs; wherein G is a group represented by the general formula (G-1) or (G-2) and all other variables are as defined in the specification.
Patent NZ-552713-A (NZ)
Title: Crystallization of anti-VEGF antibodies or fragments thereof using divalent cations
Inventor: HAGEWIESCHE ANNETTE MARIE CLASEN
IPC: A61K9/16
Filed: 2005-07-22
Abstract: Disclosed is a method for producing crystals of an anti-VEGF antibody or functional fragment thereof for use in therapeutic or diagnostic applications comprising: a) contacting an anti-VEGF antibody or functional fragment thereof with a solution that comprises about 1 to 500 mM of a salt of either ZnCl2 or MgCI2 and about 1 to 100 mM buffer; and b) incubating the antibody or functional fragment thereof and the solution until crystals of the antibody or functional fragment thereof are formed.
Patent NZ-563212-A (NZ)
Title: Procedure for accessing an electronic device by a data terminal
Inventor: NGUYEN KIM
IPC: G06F21/62
Filed: 2006-05-24
Abstract: Disclosed is a method for a data terminal (100) to access one of a number of data objects (104), stored in an electronic device (102). The electronic device features an allocation table (106), in which cryptographic protocols (108) of different security levels are assigned to the different data objects, where each of the cryptographic protocols is used to authenticate the data terminal (100). The implementation of the cryptographic protocol assigned to one of the data objects in the allocation table is a condition for access by the data terminal to this data object. The method comprises the steps of: transmission (216) of a request by data terminal (100) to the electronic device for the one particular data object; specification (218) of a cryptographic protocol for the data object with the help of the allocation table, by the electronic device; implementation (222) of the cryptographic protocol by the electronic device and data terminal (100); and transmission (220) of the data object by the electronic device, where the electronic device (102) is integrated into an identifying document (114).
Patent NZ-574635-A (NZ)
Title: Thermophilic microorganisms for ethanol production
Inventor: ATKINSON ANTHONY
IPC: C12N9/04
Filed: 2007-09-28
Abstract: Provided is a thermophilic microorganism of Geobacillus species, wherein the microorganism is modified to permit the increased production of ethanol, wherein a first modification is the inactivation of the lactate dehydrogenase gene and a second modification upregulates the pyruvate dehydrogenase gene, wherein the lactate dehydrogenase gene, or a portion thereof, has been deleted. Further provided is animal feed comprising the microbe.
Patent NZ-574925-A (NZ)
Title: Container system for peritoneal dialysis solutions having a first a compartment containing with PD osmotic agent and a second compartment with a PD buffer agent
Inventor: JENSEN LYNN E
IPC: A61M1/00
Filed: 2007-07-27
Abstract: Disclosed is a container system (10) for peritoneal dialysis (PD) solutions. The system includes a first compartment (12a) that contains a PD osmotic agent (14) and a second compartment (20a) that contains a PD buffer agent (22). The compartments maintain their respective contents separately from one another for purposes of transport, storage and/or sterilization. However, the compartments are fluidly couplable, so that their respective contents can be combined with one another, e.g., following sterilization of the agents and prior to their introduction into the patient's abdomen. The system has a protective structure which inhibits breaking of a seal (26) between the second compartment and an outlet of the system, prior to breaking of a seal (24) between the first and second compartments. (61) Addition to 556770
Patent NZ-575115-A (NZ)
Title: Regulatory nucleic acid elements
Inventor: ENENKEL BARBARA
IPC: C12N15/67
Filed: 2007-06-15
Abstract: The invention relates to DNA sequences that have transcription- or expression-increasing elements (TE-elements). The sequences are used in an expression vector in connection with an enhancer, a promoter, a product gene and a selection marker. The sequence SEQ ID NO: 1 is from a sequence region being upstream of the coding region of the Ub/S27a-gene from CHO cells. The TE-elements cause an increase in the expression of the product gene with stable integration into the eukaryotic genome, preferably the CHO-DG44-genome. Integration of the sequence can overcome, shield or cancel out chromosomal positioning effects.
Patent NZ-576245-A (NZ)
Title: A method for sharing functionality and/or data between two or more linked entities
Inventor: DEVONSHIRE KARYN JUDITH
IPC: H04L9/32
Filed: 2007-10-15
Abstract: A method and a computer program for sharing functionality and/or data between two or more linked entities using a network are disclosed. The program resides on each entity and comprises (a) a routine for creating at least one real object with each real object providing access to the functionality and/or data of the entity; (b) a routine for creating at least one virtual object with each virtual object providing access to the functionality and/or data of a real object on the entity and each virtual object containing at least one object actions; (c) a routine for creating at least one remote object for connection to a virtual object on a remote entity via the network; the remote object allowing an entity to access functionality and/or data of a remote entity and (d) a routine for creating on at least one entity a meta-object with the meta-object providing access to the functionality and/or data of a plurality of virtual, remote and meta-objects on that entity.
Patent NZ-576300-A (NZ)
Title: Antimicrobial composition useful for preserving wood containing copper 8-hydroxyquinoline (oxine copper) and an alkylbenzyldimethylammonium salt
Inventor: ASHMORE JOHN WILLIAM
IPC: A01N33/04
Filed: 2006-06-08
Abstract: Disclosed is a synergistic antimicrobial composition comprising a copper alkylbenzyldimethylammonium salt and copper 8-hydroxyquinoline, wherein the weight ratio of the copper alkyl benzyldimethylammonium salt to copper 8-hydroxyquinoline is from 1:0.8 to 1:12.5. Also disclosed is a method of inhibiting the growth of microorganisms, comprising applying the above composition. (62) Divided Out of 563783
Patent NZ-577717-A (NZ)
Title: A stable glutaraldehyde complex comprising a PVP polymer and an alcohol ethoxylate surfactant
Inventor: MARTIN ANTONIETTA PAMELA
IPC: A01N59/16
Filed: 2007-12-14
Abstract: Disclosed is a stable glutaraldehyde polymer complex solution which includes: (a) glutaraldehyde (OCH(CH2)3CHO); (b) an alcohol ethoxylate surfactant; (c) a sufficient amount of a pH modifier to bring the pH 5 of the solution to within a 6.0 to 9.0 range; (d) a buffer to maintain the pH of the solution within the range 6.0 to 9.0; and (e) a polyvinylpyrrolidone polymer. Also disclosed is the use of the glutaraldehyde polymer complex in methods of preserving fish and prolonging the shelf life of fresh meat.
Patent NZ-580217-A (NZ)
Title: Production of proanthocyanidins to improve forage quality
Inventor: DIXON RICHARD A
IPC: A23K10/32
Filed: 2008-04-23
Abstract: Disclosed are methods and compositions for the modulation of anthocyanin and proanthocyanidin production in plants using LAP polypeptides. The specification discloses sequences for these polypeptides, and their use to transform plants, particularly food and forage crops.
Patent NZ-583376-A (NZ)
Title: Hydrocarbon-adsorbing porous pavement structure
Inventor: KAUL JOSEPH B
IPC: E01C7/30
Filed: 2008-09-05
Abstract: Disclosed is a water-pervious pavement structure comprising: (a) wearing course comprising a water-pervious combination of recycled glass particles and aggregate particles bound together with an adhesive binder and held within a plurality of connected, open grid pockets; and (b) a layer of unbound recycled glass disposed under the wearing course capable of adsorbing contacting hydrocarbons carried with water through the wearing course. Also disclosed is a method for constructing a porous pavement structure capable of capturing hydrocarbon contaminants carried by rain water.
Patent NZ-587918-A (NZ)
Title: Apparatus and methods for flow cytometry sex sorting of animal sperm
Inventor: DURACK GARY
IPC: C12N5/071
Filed: 2004-03-29
Abstract: A flow cytometry system for sorting sperm in particular with at least two different characteristics includes a fluid delivery system for delivering a fluid containing the particles, a flow cytometry apparatus for receiving the fluid, forming the fluid into a fluid stream, orienting the particles within the stream and using flow cytometry to classify the particles according to the characteristics, and a sorting system for sorting the particles according to the classification and a sorting strategy to provide at least one population containing desired particles. The system includes an analog to digital converter synchronously sampling a time-varying analog output from the flow cytometry apparatus and providing an output including digital information corresponding to the time-varying analog output, both signals being indicative of the respective characteristics of the particles, and a digital signal processor analyzing and classifying the digital information and providing a sorting signal to the sorting system as a function of the analysed and classified digital information.
Patent NZ-588758-A (NZ)
Title: Spring-loaded drill rod handling device made from two clamp assemblies connected by pivot rod and locking device
Inventor: DAVIDSON ZALES DAVID
IPC: E21B19/14
Filed: 2009-06-03
Abstract: Disclosed is a rod handling device for drilling rigs to allow more efficient and safer handling of drill pipes. The device comprises a pivot rod; a first clamp assembly pivotingly coupled to the pivot rod; a second clamp assembly pivotingly coupled to the pivot rod; at least one locking assembly configured to move between a locked position and an unlocked position. In the locked position the locking assembly prevents rotation between the first clamp assembly and the second clamp assembly. A biasing member coupled to the pivot rod, the biasing member being configured to urge the locking assembly toward the locked position. The locking assembly includes a positive engagement feature associated with the first clamp assembly and a negative engagement feature associated with the second clamp assembly, wherein engagement is between the positive engagement feature and the negative engagement feature. The biasing member exerts a biasing force on at least one of the clamp assembly and the second clamp assembly to urge engagement between the positive engagement feature and the negative engagement feature.
Patent NZ-590503-A (NZ)
Title: Quinoxalinedione derivatives
Inventor: CRAVO DANIEL
IPC: A61P3/10
Filed: 2009-05-19
Abstract: Disclosed are hydroquinoxaline-2,3-dione compounds. The compounds are used to treat metabolic syndrome, diabetes, obesity, cancer, inflammation or cardiovascular diseases.
Patent NZ-591200-A (NZ)
Title: Microwave cooking container with a shielded compartment and lid a predetermined distance apart to prevent arcing
Inventor: HODSON JAY DANIEL
IPC: A47G23/06
Filed: 2011-02-16
Abstract: Disclosed is a microwave cooking container with a shielded compartment and lid spaced a predetermined distance apart to prevent arcing or sparking. A container includes at least one compartment with a base and sidewalls. The compartment has a first shield made of a material opaque to microwave energy. The first shield is disposed on an inner or outer surface of both the base and the sidewalls. The container includes a lid configured seal with the compartment. The lid has a second shield made of a material opaque to microwave energy. The second shield is disposed on the lid at a predetermined distance from the sidewalls of the compartment so as to prevent arcing or sparking. The predetermined distance is at least one eighth of an inch.
Patent NZ-591374-A (NZ)
Title: Novel imidazolidine compounds as androgen receptor modulators
Inventor: NIQUE FRANCOIS
IPC: A61K31/4166
Filed: 2009-09-10
Abstract: Disclosed is a compound of formula (Ib), wherein the substituents are as defined in the specification.  The compounds are androgen receptor modulators useful in the treatment of conditions such as cachexia, osteoporosis, sarcopenia, or a decline in libido and/or sexual dysfunction, as well as androgen dependent tumours, such as prostate cancer or hyerplasia.
Patent NZ-592717-A (NZ)
Title: Aerosol fluoroquinolone formulations for improved pharmacokinetics comprising levofloxacin or ofloxacin and a di- or trivalent cation
Inventor: GRIFFITH DAVID C
IPC: A61K31/4375
Filed: 2009-10-06
Abstract: Disclosed is the use of a solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation for the preparation of an aerosol for treating a pulmonary infection, wherein the aerosol can achieve a maximum lung sputum concentration (Cmax) of at least 1200 mg/L and a lung sputum area under the curve (AUC) of at least 1500 h·mg/L, wherein the solution comprises a divalent or trivalent cation concentration from about 50 mM to about 400 mM, and a levofloxacin or ofloxacin concentration from between about 50 mg/ml to about 200 mg/ml.
Patent NZ-598705-A (NZ)
Title: Protein kinase conjugates and inhibitors
Inventor: SINGH JUSWINDER
IPC: G01N33/53
Filed: 2010-09-15
Abstract: 598705 Disclosed is A protein kinase conjugate that has the formula, X-M-S-CH2-Prot wherein, Prot is a protein kinase or portion thereof that contains a cysteine residue selected from the group consisting of CYS1, CYS5, CYS6, CYS7, CYS8, CYS9, CYS10, CYS11, CYS12 and CYS13; S-CH2 is the sulfur atom and methylene group from the side chain of said cysteine residue; M is a modifier moiety that is formed by the covalent bonding of a warhead group with the side chain of said cysteine residue; and X is a chemical moiety that binds in or near the ATP binding site of the protein kinase.
Patent NZ-600118-A (NZ)
Title: Lipopeptide compositions and related methods
Inventor: SUN SOPHIE
IPC: A61K38/12
Filed: 2010-11-23
Abstract: The present disclosure provides novel powder daptomycin formulations which have improved chemical stability and faster reconstitution times when in the solid state. The formulation may be a solid pharmaceutical daptomycin composition characterised in that an amount of the solid pharmaceutical daptomycin composition containing 500 mg of daptomycin dissolves in 10 mL of 0.9% aqueous sodium chloride in less than 5 minutes at about 25 degrees C, the solid pharmaceutical daptomycin composition comprising daptomycin and at least one excipient selected from glycine and a sugar. Some examples of the compositions comprise daptomycin and sucrose.
Patent NZ-602843-A (NZ)
Title: Method and apparatus for channel quality reporting in a wireless communication system
Inventor: NORDSTROM FREDRIK
IPC: H04B7/06
Filed: 2011-04-01
Abstract: A method of reporting channel quality from a first communication transceiver and a first communication transceiver are disclosed. The first communication transceiver (10) comprises a receiver (26) configured to receive antenna-specific reference signals from a second communication transceiver (12) that supports multi-rank and single-rank transmission to the first communication transceiver; a channel estimation circuit (22) configured to generate channel estimates from the received reference signals and one or more processing circuits (24) configured to determine whether multi-rank transmission by the second communication transceiver is desired, based on evaluating channel conditions as estimated from the reference signals. When multi-rank transmission is desired, one or more processing circuits are configured to send a multi-rank Channel Quality Information (CQI) report to the second communication transceiver that reports two or more CQI values for use in adapting multi-rank transmission to the first communication transceiver, using a reporting order that dictates which reported CQI value or values are reported as absolute values and which reported CQI value or values are reported as offsets relative to one or more of the absolute values, using a bounded differential reporting format; and dynamically determine the reporting order, to reduce under-reporting or over-reporting errors that arise from the use of the bounded differential reporting format.
Patent NZ-604092-A (NZ)
Title: Permeant delivery system and methods for use thereof
Inventor: ENSCORE DAVID
IPC: A61M37/00
Filed: 2009-03-31
Abstract: The present disclosure relates generally to the field of transdermal permeant delivery and more specifically to devices, systems and methods for using the same. More specifically the disclosure relates to patch for delivering a permeant through a biological membrane of a subject comprising: a) a matrix; b) at least one hydrophilic permeant disposed within the matrix, wherein at least a portion of the hydrophilic permeant can dissolve in biological moisture received from the subject; c) at least one permeability enhancer disposed within the matrix; and at least one of the following d1) and d2): d1) at least one water soluble polymer disposed within the matrix, wherein the water soluble polymer is at least one selected from the group consisting of: polyethylene glycol, polyvinyl alcohol, and polyvinylpyrrolidone; and d2) at least one solubility control agent selected from the group consisting of agents that selectively control pH of a solution relative to the isoelectric point of the hydrophilic permeant, ionic strength control agents, and salting-out agents, wherein when the patch does not comprise the at least one water soluble polymer, the hydrophilic permeant is at least one bioactive agent selected from the group consisting of peptides, polypeptides, proteins, oligonucleotides, nucleic acids, polysaccharides, and undissolved anhydrous hydrophilic salts excluding hydromorphone HCl. The disclosure also relates to a system comprising the above that additionally comprises a porator. Reference has been directed, in pursuance of section 16(1) of the Patents Act 1953, to patent No. 588883.
Patent NZ-621477-A (NZ)
Title: System and method for processing sensor data for the visually impaired
Inventor: LUI WEN LIK DENNIS
IPC: G06T1/00
Filed: 2012-08-29
Abstract: A prosthetic processing apparatus (200) for use by a visually-impaired subject comprises at least one sensor configured to capture and output physical information of a spatial field, an output interface (208) coupled to a sensory input device which is configured to apply a signal to a sensory pathway of the visually impaired subject, and a processor (202) operatively coupled to the sensor and to the output interface (208). The processor (202) is configured to receive the physical information of the spatial field from the sensor and to process the received information to identify one or more salient features of a predetermined category (such as edges, plane surfaces, human faces and/or bodies) within the spatial field. The processor (202) is further configured to generate a transformed representation of the spatial field in which each identified salient feature is represented in a symbolic form subject to predetermined fidelity constraints imposed by capability of the sensory input device. The transformed representation is then output from the processor (202) to the sensory input device via the output interface (208).
Patent NZ-625844-A (NZ)
Title: 4’-azido, 3’-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
Inventor: ZHANG JING
IPC: C07H19/16
Filed: 2012-12-17
Abstract: Provided are 4’-azido, 3’-fluoro substituted nucleoside phosphoramidate derivative compounds of the general formula I, where the variables are as defined in the specification. Examples of the compounds include S)-2-{ [(2R,3S,4S,SR)-2-Azido-S-(2,4-dioxo-3 ,4-dihydro-2H-pyrimidin-1-yl)-3-fluoro-4-hydroxy-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino} -propionic acid isopropyl ester and (S)-2-[[(2R,3S,4S,5R)-5-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-2-azido-3-fluoro-4-hydroxy-tetrahydro-furan-2-1-6ylmethoxy]-(naphthalen-1-yloxy)-phosphorylamino]-propionic acid ethyl ester. The compounds are inhibitors of hepatitis C virus (HCV) RNA replication.
Patent NZ-626044-A (NZ)
Title: Chlorine detection and ph sensing methods and apparatus
Inventor: KLAUS BRONDUM
IPC: C01B11/04
Filed: 2014-03-13
Abstract: Disclosed is a method for measuring the pH of a salt water solution comprising, measuring the UV absoprtion of a first sample of the first solution; subjecting the solution to electrolysis to generate a catholyte; measuring the UV absorption of the catholyte; and determining the pH of the solution using the absorption values. Also disclosed is a tangible computer storage medium which is operable to receive UV absorption values of a solution and a catholyte thereof and determine the pH of the solution using the first and second absorption values.